Effects of Radon Exposure: What Homeowners Need to Know
The effects of radon exposure are health risks that develop slowly over years of inhaling radon decay products, with lung cancer being the dominant documented effect at residential exposure levels. The EPA estimates radon causes approximately 21,000 lung cancer deaths per year in the United States, making it the second leading cause of lung cancer after smoking and the leading cause among non-smokers. The relationship between exposure and risk follows what regulators call a linear no-threshold model: doubling exposure roughly doubles risk, with no documented safe lower limit. This guide summarizes EPA, CDC, NIH, NIEHS, and CDPHE guidance current as of 2026 on the documented health effects, the science behind the dose-response relationship, the smoker interaction effect, and what homeowners can do. Consult your physician for any respiratory symptoms or exposure concerns and a certified radon professional for testing and mitigation decisions.
What are the documented effects of radon exposure?
Lung cancer is the only well-documented health effect of long-term residential radon exposure in adult humans. Radon itself is chemically inert and does not stay in the lungs; however, radon decay products (polonium-218 and polonium-214) emit alpha particles that lodge in lung tissue when inhaled. Alpha particle energy damages DNA in bronchial epithelial cells, and accumulated damage over years to decades can produce lung cancer. The EPA, CDC, NIH, and World Health Organization all classify radon as a known human carcinogen (Group 1, IARC).
Other potential effects (childhood leukemia, stomach cancer, chronic respiratory issues) have been investigated in epidemiological studies but none has reached the level of established causal evidence at typical residential exposure levels. The broader picture of radon in Colorado housing sits on the radon testing pillar for Front Range homeowners.
The dose-response relationship
Radon health risk is calculated based on three variables: concentration of radon in inhaled air (measured in pCi/L), duration of exposure, and individual susceptibility (especially smoking history). The relationship is approximately linear: doubling either the concentration or the years of exposure roughly doubles the lung cancer risk. EPA’s published risk estimates show:
At 20 pCi/L lifetime average exposure, about 36 of 1,000 lifetime non-smokers are estimated to develop radon-attributable lung cancer. For lifetime smokers at the same concentration, the rate jumps to about 260 of 1,000.
At 8 pCi/L, the rates are about 15 of 1,000 non-smokers and 120 of 1,000 smokers.
At 4 pCi/L (the EPA action level), the rates are about 7 of 1,000 non-smokers and 62 of 1,000 smokers.
At 2 pCi/L, the rates are about 4 of 1,000 non-smokers and 32 of 1,000 smokers.
These are population-level risk estimates, not individual diagnoses. They reflect the combined evidence from miner cohort studies and residential case-control studies pooled by EPA, BEIR VI, and the WHO Handbook on Indoor Radon.
Why smokers face dramatically higher risk
The smoker interaction is one of the strongest documented effects in radon epidemiology. Tobacco smoke and radon decay products work synergistically: smoking damages the bronchial mucociliary clearance mechanism, allowing radon progeny to deposit and remain longer in the lung. Smoking also damages DNA repair pathways, compounding alpha-particle damage. The combined risk is roughly 10 times the risk to non-smokers at the same radon exposure level. EPA, CDC, and the U.S. Surgeon General all emphasize that radon exposure plus smoking is the single highest-risk combination short of occupational uranium mining.
For households where any occupant smokes, radon mitigation produces substantially larger absolute risk reductions than in non-smoking households at the same starting concentration.
Latency and timing of effects
Radon-induced lung cancer typically appears 5 to 25 years after sustained exposure begins. Children and adolescents may face higher relative risk because their lung tissue is still developing and they have more years of exposure ahead. CDC guidance is clear that exposure during childhood matters for lifetime risk. Pregnant individuals do not face specific documented radon-related fetal risks at residential levels, but EPA still recommends mitigation as a household-wide measure.
Short-term high-level exposure (a few weeks at very high concentrations) does not produce immediate respiratory illness or acute symptoms. There is no “radon poisoning” syndrome that develops over hours or days. The danger is the slow accumulation of cellular damage that may not manifest as cancer for decades.
What radon exposure does not cause
Several common public concerns are not supported by current evidence. Radon does not cause headaches, fatigue, dizziness, or other acute symptoms at residential levels. Radon does not stay in the body and does not bioaccumulate; once inhaled, it is exhaled within minutes. Radon decay products do deposit in lung tissue but are removed by mucociliary clearance over hours to days. Persistent respiratory symptoms in a high-radon home likely have other causes (allergens, mold, viral illness) and should be evaluated by a physician.
How exposure is measured in practice
Personal exposure is calculated from the home’s measured radon concentration (in pCi/L) multiplied by the fraction of time the occupant spends in the home (typically estimated at 70 to 80 percent for residential occupants) and the years of residence. The result is expressed in working-level-months (WLM) for occupational comparison or in cumulative pCi/L-years for residential studies. The numerical exposure metric matters less than the practical takeaway: lower long-term concentration equals lower lifetime risk.
For homeowners, the easiest first step is a 48-hour short-term test to determine current concentration. The radon testing cost guide covers professional testing options.
Front Range geography and exposure
Most of Colorado’s Front Range is EPA Radon Zone 1 (highest predicted indoor radon levels). CDPHE estimates that approximately half of Colorado homes test above 4 pCi/L; some counties run higher. Geological factors include uranium-bearing granitic bedrock, alluvial deposits along the foothills, and weathered Pierre shale. These geological features produce above-average soil-gas radon that enters homes through foundation cracks, sump pump openings, and utility penetrations. Homes built on uranium-rich soil routinely test above EPA action levels regardless of home age or construction quality.
What homeowners can do
Three actions reduce lifetime exposure risk meaningfully:
1. Test
Every home below the third floor should be tested at least once. Re-test every 2 to 5 years even after a low initial reading. Re-test after major construction or HVAC changes.
2. Mitigate if elevated
Sub-slab depressurization (SSD) is the standard mitigation method and reduces indoor radon by 50 to 99 percent in most homes. Installation runs $1,500 to $3,500 on the Front Range. EPA recommends mitigation at or above 4 pCi/L and consideration of mitigation between 2 and 4 pCi/L.
3. Eliminate smoking in the home
Because the smoker-radon interaction multiplies risk roughly tenfold, smoking cessation or eliminating indoor smoking is one of the largest single risk-reduction measures available to a household with elevated radon.
Medical follow-up after high exposure
For individuals who have lived in a home with documented high radon (above 10 pCi/L) for many years, particularly with a smoking history, low-dose CT lung cancer screening may be appropriate. The U.S. Preventive Services Task Force currently recommends annual low-dose CT screening for current or former smokers ages 50 to 80 with at least a 20 pack-year history. Patients without that smoking history but with significant radon exposure should discuss screening options with their physician. CDC and NIH publish patient-oriented resources on lung cancer screening eligibility.
How risk estimates are calculated
EPA’s risk estimates come from two main data sources. The first is the BEIR VI report (Health Effects of Exposure to Radon, National Research Council, 1999) which pooled epidemiological data from 11 cohorts of uranium miners and extrapolated to residential exposure conditions. The second is a 2005 pooled analysis of 13 European residential case-control studies and a separate pooled North American analysis, both of which confirmed BEIR VI’s residential predictions using direct residential exposure data.
The miner cohort data and residential case-control data converge on similar dose-response relationships when adjusted for exposure rate and lung biology differences. The agreement between these independent data sources strengthens the EPA’s confidence in the published risk estimates. NIH and NIEHS continue to fund research on radon-related cancer mechanisms, particularly the molecular biology of alpha-particle DNA damage.
Comparing radon risk to other indoor hazards
EPA’s published comparisons place radon-attributable lung cancer mortality (about 21,000 per year in the U.S.) significantly above other common residential health risks:
Carbon monoxide poisoning: approximately 400 deaths per year (CDC).
Residential fires: approximately 3,500 deaths per year (NFPA).
Drowning (residential pools): approximately 350 deaths per year (CDC).
Radon represents a residential health risk on par with motor-vehicle fatalities in scale, yet receives a fraction of the attention. The reason is largely the long latency: radon-attributable lung cancer manifests decades after exposure, making it harder to connect cause to effect in public perception.
The role of ventilation
Beyond mitigation systems, basic ventilation reduces radon concentration somewhat. Opening windows, running bathroom and kitchen exhaust fans, and ensuring HVAC fresh-air intakes are functioning all dilute indoor radon. However, ventilation alone is rarely sufficient to bring elevated levels below the EPA action level. Sub-slab depressurization is the engineered solution that actually addresses the entry pathway rather than diluting after the fact. EPA-published guidance is explicit that ventilation is a complement to, not a substitute for, proper mitigation.
References
- EPA health risk of radon — U.S. Environmental Protection Agency
- CDC radon facts — Centers for Disease Control and Prevention
- NIEHS radon health overview — National Institute of Environmental Health Sciences
- CDPHE radon program — Colorado Department of Public Health and Environment
- American Lung Association radon guidance — American Lung Association
Front Range homeowners concerned about radon exposure in their home can connect through our contact page for a referral to a certified radon measurement and mitigation professional.